简体中文English

MYB (6q23) gene breakage probe reagent
Wholesale Price(RMB):

30006000330066003300660036007200

Product Code:R-0501367Ⅰ-01/R-0501367Ⅰ-02/R-0501367Ⅱ-01/R-0501367Ⅱ-02/R-0501367Ⅲ-01/R-0501367Ⅲ-02/R-0501367Ⅳ-01/R-0501367Ⅳ-02
Probe name:GSP MYB(Centromere)/ GSP MYB(Telomere)
Product Code:Type I (direct FISH method)/Type II (biotin-labeled indirect FISH method)/Type III (digoxigenin-labeled indirect FISH method)/Type IV (TSA-FISH method)
Registration Number:
Clinical Value

Salivary gland tumors


Adenoid cystic carcinoma (ACC) has bi-directional differentiation between ductal epithelium and myoepithelium, and is mainly distinguished from pleomorphic adenomas, basal cell adenomas and adenocarcinomas, epithelial-myoepithelial carcinomas, and pleomorphic low-grade malignant adenocarcinomas, etc. About 50% of salivary gland tumors show specific MYB-NFIB fusion gene abnormality. A specific MYB-NFIB fusion gene abnormality is seen in about 50% of adenoid cystadenocarcinomas; this fusion gene abnormality is not seen in other salivary gland tumors or non-salivary gland tumors.MYB protein expression is commonly found in adenoid cystadenocarcinomas (about 80%), but is less specific (about 14% are also expressed in non-salivary gland tumors).


Tumors of the central nervous system


The 2021 edition of the CNS classification names two new molecular subtypes associated with MYB gene translocations: “diffuse astrocytoma, MYB or MYBL1 variant” and “angiocentric glioma”.